| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,980,500 | 15,505,300 | 15,495,800 | 15,069,600 | | Cost of Revenue | (233,700) | 121,300 | 112,400 | (36,169,200) | | | Gross Profit | 15,214,200 | 15,384,000 | 15,383,400 | 51,238,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,159,500 | 14,055,800 | 13,953,300 | 50,544,000 | | Non Recurring | 205,500 |
-
|
-
|
-
| | Others | (378,600) | 511,200 | 67,900 | 71,100 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,227,800 | 817,000 | 1,362,200 | 623,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 352,500 | (352,500) |
-
| | Earnings Before Interest And Taxes | 1,227,800 | 1,169,500 | 1,009,700 | 623,700 | | Interest Expense | 110,600 | 117,000 | 116,100 | 115,900 | | Income Before Tax | 1,117,200 | 1,052,500 | 893,600 | 507,800 | | Income Tax Expense | 387,000 | 359,000 | 313,200 | 176,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 730,200 | 693,500 | 580,400 | 331,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 730,200 | 693,500 | 580,400 | 331,400 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $730,200 | $693,500 | $580,400 | $331,400 |
|
1.52% Nasdaq 0.00%
Income Statement
